menu
    • menu
    [{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"U.S.A","productType":"Probiotic","year":"2015","type":"Inapplicable","leadProduct":"Lactobacillus Acidophilus","moa":"Undisclosed","graph1":"Immunology","graph2":"Phase II","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Sachet","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"8","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Phosphatidylserine","moa":"Phosphatidylserine decarboxylase proenzyme, mitochondrial; Scavenger receptor class B member 1; Protein kinase C alpha type; Phosphatidylserine synthase 1; Diacylglycerol kinase gamma; Diacylglycerol kinase delta; Phosphatidylserine synthase 2; Sphingomyelin phosphodiesterase 4; Sphingomyelin phosphodiesterase 3; Phospholipid-transporting ATPase IA","graph1":"Neurology","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Gummies","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Microorganism","year":"2012","type":"Inapplicable","leadProduct":"Rhinovirus","moa":"Rhinovirus","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"NEW ZEALAND","productType":"Probiotic","year":"2011","type":"Inapplicable","leadProduct":"B. Lactis Hn019","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Phase III","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"10","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2012","type":"Inapplicable","leadProduct":"Blend","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ Undisclosed"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"University of Colorado, Denver","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"U.S.A","productType":"Undisclosed","year":"2015","type":"Inapplicable","leadProduct":"Colorado Diet","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ University of Colorado, Denver","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ University of Colorado, Denver"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2012","type":"Inapplicable","leadProduct":"Dry-Blended Beverage","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ Undisclosed"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"D","therapeuticArea":"Gastroenterology","country":"U.S.A","productType":"Probiotic","year":"2020","type":"Collaboration","leadProduct":"Gut-Microbiome","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Discovery","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Discovery","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"2","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"UNITED KINGDOM","productType":"Probiotic","year":"2018","type":"Inapplicable","leadProduct":"Lactobacillus Paracasei","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"CANADA","productType":"Plant Extract\/Herbal","year":"2014","type":"Inapplicable","leadProduct":"Litesse Powder Containing Polydextrose","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Phase II","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"8","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"MRM Health","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"BELGIUM","productType":"Microorganism","year":"2022","type":"Collaboration","leadProduct":"M008","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Preclinical","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"4","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Protein","year":"2013","type":"Inapplicable","leadProduct":"Soy Dairy Protein","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ Undisclosed"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Protein","year":"2014","type":"Inapplicable","leadProduct":"Soy Protein","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"MRM Health","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"BELGIUM","productType":"Undisclosed","year":"2020","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0.02,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0.02,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"AUSTRALIA","productType":"Undisclosed","year":"2018","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Phase II","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ International Flavors and Fragrances","highestDevelopmentStatusID":"8","companyTruncated":"International Flavors and Fragrances \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"Arne Astrup","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Alginic Acid Excipient","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ Arne Astrup","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ Arne Astrup"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"Daacro","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"U.S.A","productType":"Undisclosed","year":"2018","type":"Inapplicable","leadProduct":"Lpc-37","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Flavors and Fragrances \/ Daacro","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ Daacro"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"Vastra Gotaland Region","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Probiotic","year":"2017","type":"Inapplicable","leadProduct":"Probion Clinica","moa":"Undisclosed","graph1":"Oncology","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"International Flavors and Fragrances \/ Vastra Gotaland Region","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ Vastra Gotaland Region"}]

    Find Clinical Drug Pipeline Developments & Deals by International Flavors and Fragrances

    Menu

    International Flavors and Fragrances

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : M008

                            Therapeutic Area : Endocrinology

                            Study Phase : Preclinical

                            Recipient : MRM Health

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program

                            Details : MRM Health, working in conjunction with International Flavors & Fragrances, is advancing the LBP candidate M008 for treating NAFLD/NASH. The proprietary MRM Health CORAL® technology platform and some IFF strains will be combined to develop novel therape...

                            Product Name : Undisclosed

                            Product Type : Microorganism

                            Upfront Cash : Undisclosed

                            December 12, 2022

                            Lead Product(s) : M008

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Preclinical

                            Recipient : MRM Health

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Phosphatidylserine

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Recipient : Northumbria University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in ...

                            Details : Phosphatidylserine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition Disorders.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            January 05, 2022

                            Lead Product(s) : Phosphatidylserine

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Recipient : Northumbria University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Gut-Microbiome

                            Therapeutic Area : Gastroenterology

                            Study Phase : Discovery

                            Recipient : Rutgers University

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            DuPont Nutrition & Biosciences Announces Research Collaboration with Rutgers University

                            Details : The two-year research partnership will focus on improving the benefit/risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to potentially improve response rates through modulation of the microbiome.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Undisclosed

                            July 23, 2020

                            Lead Product(s) : Gut-Microbiome

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Discovery

                            Recipient : Rutgers University

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Alginic Acid Excipient

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Arne Astrup

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Food Structure and Satiety

                            Details : Alginate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            February 28, 2020

                            Lead Product(s) : Alginic Acid Excipient

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Arne Astrup

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Recipient : MRM Health

                            Deal Size : $15.1 million

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            DuPont Nutrition & Biosciences Enters into Collaboration

                            Details : In collaboration, proprietary MRM Health technology platform and some selected DuPont strains will be combined to develop novel therapeutics based on live bacterial strain combinations.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Undisclosed

                            February 19, 2020

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Recipient : MRM Health

                            Deal Size : $15.1 million

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Phase II

                            Recipient : Swinburne University of Technology

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Examining the Effects of One-Month Probiotic Treatment on Mental Fatigue

                            Details : This drug candidate is currently being evaluated in phase II clinical studies for the treatment of Mental Fatigue.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            August 02, 2018

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Phase II

                            Recipient : Swinburne University of Technology

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactobacillus Paracasei

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Recipient : Northumbria University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Cognitive Effects of 6 Weeks Administration With a Probiotic

                            Details : Lactobacillus Paracasei is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition Disorders.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            July 26, 2018

                            Lead Product(s) : Lactobacillus Paracasei

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Recipient : Northumbria University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lpc-37

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Undisclosed

                            Sponsor : Daacro

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Stress & Anxiety Dampening Effects of a Probiotic Supplement Compared to Placebo in Healthy Subjects

                            Details : Lpc-37 is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Stress, Psychological.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            April 11, 2018

                            Lead Product(s) : Lpc-37

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Undisclosed

                            Sponsor : Daacro

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Probion Clinica

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Sponsor : Vastra Gotaland Region

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Using Probiotics to Reactivate Tumor Suppressor Genes in Colon Cancer

                            Details : Probion Clinica is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Colonic Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            March 07, 2017

                            Lead Product(s) : Probion Clinica

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Sponsor : Vastra Gotaland Region

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            International Flavors and Fragrances

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactobacillus Acidophilus

                            Therapeutic Area : Immunology

                            Study Phase : Phase II

                            Recipient : Connecticut Children's Medical Center

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adeniti...

                            Details : Lactobacillus acidophilus is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Fever.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            August 31, 2015

                            Lead Product(s) : Lactobacillus Acidophilus

                            Therapeutic Area : Immunology

                            Highest Development Status : Phase II

                            Recipient : Connecticut Children's Medical Center

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth